Why Did Citius Oncology Plunge 8.06% After 84.96% Surge?

Citius Oncology's stock price dropped 8.06% in pre-market trading on April 1, 2025.

Citius Oncology has experienced significant volatility in recent trading sessions. On March 31st, the stock surged 84.96% to $1.23 in pre-market trading. This dramatic increase followed a 64% jump in the previous session, adding to a 1.5% gain from the session before. The company's market cap stands at $12.1 million, reflecting its recent performance.

Despite the recent gains, Citius Oncology's stock price has seen a 44.12% decline over the past month. This volatility highlights the speculative nature of the stock, which can be influenced by various factors including market sentiment and company-specific news.

Investors should closely monitor Citius Oncology's performance and consider the potential risks and rewards associated with investing in a highly volatile stock. The company's recent gains and losses underscore the importance of thorough research and a well-diversified investment portfolio.